Skip to content

ACTAVIA LIFE SCIENCES, INC.: 10-Q filed 2016-11-21

What ACTAVIA LIFE SCIENCES, INC. reported in its quarterly report filed 2016-11-21 (fiscal Q2 2017): 22 published measures, 64 facts as tagged in accession 0001144204-16-135471.

This filing

Form
10-Q (quarterly report)
Filed
2016-11-21
Fiscal period
fiscal Q2 2017
Accession
0001144204-16-135471 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ACTAVIA LIFE SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-09-308,736,620USD
At 2016-03-311,907,159USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-09-30849,854USD
At 2016-03-31628,227USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-09-307,886,766USD
At 2016-06-308,747,658USD
At 2016-03-311,278,932USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-09-303,762,811USD
At 2016-03-310USD
At 2015-09-300USD
At 2015-03-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-1,291,370USD92
2016-04-01 to 2016-09-30-1,507,135USD183
2016-04-01 to 2016-06-30-215,765USD91
2015-07-01 to 2015-09-30-117,343USD92
2015-04-01 to 2015-09-30-224,319USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-09-30-6,331,183USD
At 2016-03-31-4,824,048USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-07-01 to 2016-09-300USD92
2016-04-01 to 2016-09-300USD183
2015-07-01 to 2015-09-300USD92
2015-04-01 to 2015-09-300USD183

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-04-01 to 2016-09-30407,468USD183
2015-04-01 to 2015-09-300USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-1,341,726USD92
2016-04-01 to 2016-09-30-1,560,152USD183
2015-07-01 to 2015-09-30-117,343USD92
2015-04-01 to 2015-09-30-224,319USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-09-303,797,410USD
At 2016-03-31607,159USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-09-30849,854USD
At 2016-03-31628,227USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-09-3030,971USD
At 2016-03-310USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2016-09-303,402,941USD
At 2016-05-173,402,941USD
At 2016-03-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-07-01 to 2016-09-301,341,726USD92
2016-04-01 to 2016-09-301,560,152USD183
2015-07-01 to 2015-09-30117,343USD92
2015-04-01 to 2015-09-30224,319USD183

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-07-01 to 2016-09-300USD92
2016-04-01 to 2016-09-300USD183
2015-07-01 to 2015-09-300USD92
2015-04-01 to 2015-09-300USD183

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-07-01 to 2016-09-30642,522USD92
2016-04-01 to 2016-09-30642,522USD183
2015-07-01 to 2015-09-300USD92
2015-04-01 to 2015-09-300USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-08-1564,679,798shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-09-3014,153,269USD
At 2016-03-315,746,477USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-09-3078,227USD
At 2016-03-3178,227USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-07-01 to 2016-09-30144,479USD92
2016-04-01 to 2016-09-30182,590USD183
2015-07-01 to 2015-09-300USD92
2015-04-01 to 2015-09-300USD183

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2016-04-01 to 2016-09-300USD183
2015-10-01 to 2016-03-310USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-07-01 to 2016-09-3050,356USD92
2016-04-01 to 2016-09-3053,017USD183
2015-07-01 to 2015-09-300USD92
2015-04-01 to 2015-09-300USD183

Inspect the source

Entity
ACTAVIA LIFE SCIENCES, INC. / CIK 0001582249
Captured
SEC response SHA-256
1fa3da8551fa6523f67ea25c9d27ef0c331ae8c1fcbc6eda23b86adc30a6f71c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001582249.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))